nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Cyclosporine—systemic lupus erythematosus	0.166	0.262	CbGbCtD
Bosentan—ABCB11—Dexamethasone—systemic lupus erythematosus	0.109	0.172	CbGbCtD
Bosentan—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0627	0.0987	CbGbCtD
Bosentan—CYP2C9—Dapsone—systemic lupus erythematosus	0.0447	0.0703	CbGbCtD
Bosentan—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0297	0.0468	CbGbCtD
Bosentan—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0293	0.0462	CbGbCtD
Bosentan—CYP3A4—Dapsone—systemic lupus erythematosus	0.026	0.0409	CbGbCtD
Bosentan—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0225	0.0355	CbGbCtD
Bosentan—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0225	0.0355	CbGbCtD
Bosentan—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0193	0.0304	CbGbCtD
Bosentan—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0193	0.0304	CbGbCtD
Bosentan—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0191	0.03	CbGbCtD
Bosentan—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0181	0.0285	CbGbCtD
Bosentan—CYP3A4—Prednisone—systemic lupus erythematosus	0.018	0.0283	CbGbCtD
Bosentan—CYP2C9—cardial valve—systemic lupus erythematosus	0.0175	0.398	CbGeAlD
Bosentan—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0171	0.0269	CbGbCtD
Bosentan—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0112	0.0177	CbGbCtD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00712	0.138	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.0051	0.0987	CbGpPWpGaD
Bosentan—CYP2C9—urine—systemic lupus erythematosus	0.00377	0.0857	CbGeAlD
Bosentan—EDNRB—cortex of kidney—systemic lupus erythematosus	0.00318	0.0722	CbGeAlD
Bosentan—CYP3A4—urine—systemic lupus erythematosus	0.00288	0.0654	CbGeAlD
Bosentan—EDNRB—tendon—systemic lupus erythematosus	0.00263	0.0599	CbGeAlD
Bosentan—EDNRA—cortex of kidney—systemic lupus erythematosus	0.00263	0.0597	CbGeAlD
Bosentan—EDNRB—lung—systemic lupus erythematosus	0.00231	0.0525	CbGeAlD
Bosentan—EDNRA—tendon—systemic lupus erythematosus	0.00218	0.0495	CbGeAlD
Bosentan—CYP2C9—blood plasma—systemic lupus erythematosus	0.00197	0.0447	CbGeAlD
Bosentan—EDNRA—lung—systemic lupus erythematosus	0.00191	0.0434	CbGeAlD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.00191	0.0369	CbGpPWpGaD
Bosentan—CYP3A4—blood plasma—systemic lupus erythematosus	0.0015	0.0341	CbGeAlD
Bosentan—ABCB11—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.00138	0.0268	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.00136	0.0264	CbGpPWpGaD
Bosentan—ABCB11—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.0012	0.0233	CbGpPWpGaD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.00119	0.0231	CbGpPWpGaD
Bosentan—ABCB11—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—RXRA—systemic lupus erythematosus	0.000999	0.0194	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—NOS3—systemic lupus erythematosus	0.000912	0.0177	CbGpPWpGaD
Bosentan—ABCB11—Synthesis of bile acids and bile salts—RXRA—systemic lupus erythematosus	0.00091	0.0176	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.0009	0.0174	CbGpPWpGaD
Bosentan—ABCB11—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000785	0.0152	CbGpPWpGaD
Bosentan—ABCB11—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000723	0.014	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000701	0.0136	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000685	0.0133	CbGpPWpGaD
Bosentan—CYP3A4—kidney—systemic lupus erythematosus	0.00068	0.0155	CbGeAlD
Bosentan—EDNRA—Endothelin Pathways—NOS3—systemic lupus erythematosus	0.000653	0.0126	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000644	0.0125	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00056	0.0108	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000502	0.00972	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000481	0.00932	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00048	0.00929	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000478	0.00925	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000455	0.00881	CbGpPWpGaD
Bosentan—CYP3A4—nervous system—systemic lupus erythematosus	0.000446	0.0101	CbGeAlD
Bosentan—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000443	0.00859	CbGpPWpGaD
Bosentan—CYP3A4—central nervous system—systemic lupus erythematosus	0.00043	0.00977	CbGeAlD
Bosentan—EDNRA—GPCRs, Other—CCR5—systemic lupus erythematosus	0.000425	0.00824	CbGpPWpGaD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.00041	0.00795	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000407	0.00788	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000401	0.00776	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000365	0.00708	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000344	0.00667	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000343	0.00665	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00033	0.00639	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000325	0.0063	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000323	0.00625	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000322	0.00624	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000315	0.00611	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000291	0.00564	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000287	0.00555	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000283	0.00548	CbGpPWpGaD
Bosentan—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000265	0.00514	CbGpPWpGaD
Bosentan—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000265	0.00513	CbGpPWpGaD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000263	0.00509	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000261	0.00507	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000258	0.005	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000256	0.00497	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000252	0.00489	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000246	0.00476	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.000236	0.00457	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000231	0.00448	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000231	0.00447	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000229	0.00443	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000226	0.00437	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000221	0.00429	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000216	0.00419	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000207	0.00402	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000206	0.004	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000205	0.00397	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000203	0.00392	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00019	0.00368	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000188	0.00363	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000185	0.00358	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000183	0.00355	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000181	0.0035	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000176	0.00341	CbGpPWpGaD
Bosentan—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000175	0.00339	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000169	0.00328	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000169	0.00326	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—C3—systemic lupus erythematosus	0.000165	0.00319	CbGpPWpGaD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.00016	0.00311	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000159	0.00309	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000158	0.00307	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000155	0.003	CbGpPWpGaD
Bosentan—Discomfort—Betamethasone—systemic lupus erythematosus	0.000153	0.000568	CcSEcCtD
Bosentan—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000153	0.000568	CcSEcCtD
Bosentan—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000153	0.000568	CcSEcCtD
Bosentan—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000153	0.000567	CcSEcCtD
Bosentan—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000153	0.000566	CcSEcCtD
Bosentan—Pain—Prednisolone—systemic lupus erythematosus	0.000152	0.000565	CcSEcCtD
Bosentan—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000152	0.000565	CcSEcCtD
Bosentan—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000152	0.000565	CcSEcCtD
Bosentan—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000152	0.000562	CcSEcCtD
Bosentan—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000151	0.000561	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000151	0.00292	CbGpPWpGaD
Bosentan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000151	0.00056	CcSEcCtD
Bosentan—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000151	0.00056	CcSEcCtD
Bosentan—Nausea—Leflunomide—systemic lupus erythematosus	0.00015	0.000559	CcSEcCtD
Bosentan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.00015	0.000558	CcSEcCtD
Bosentan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.00015	0.000557	CcSEcCtD
Bosentan—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.00015	0.000556	CcSEcCtD
Bosentan—Vision blurred—Prednisone—systemic lupus erythematosus	0.000149	0.000554	CcSEcCtD
Bosentan—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000149	0.000553	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000149	0.000553	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000149	0.000552	CcSEcCtD
Bosentan—Pain—Hydrocortisone—systemic lupus erythematosus	0.000149	0.000552	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000149	0.00288	CbGpPWpGaD
Bosentan—Oedema—Dexamethasone—systemic lupus erythematosus	0.000148	0.000551	CcSEcCtD
Bosentan—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000148	0.000551	CcSEcCtD
Bosentan—Oedema—Betamethasone—systemic lupus erythematosus	0.000148	0.000551	CcSEcCtD
Bosentan—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000148	0.000551	CcSEcCtD
Bosentan—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000148	0.000549	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000148	0.00286	CbGpPWpGaD
Bosentan—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000148	0.000548	CcSEcCtD
Bosentan—Infection—Dexamethasone—systemic lupus erythematosus	0.000147	0.000548	CcSEcCtD
Bosentan—Infection—Betamethasone—systemic lupus erythematosus	0.000147	0.000548	CcSEcCtD
Bosentan—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000147	0.000545	CcSEcCtD
Bosentan—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000147	0.000544	CcSEcCtD
Bosentan—Anaemia—Prednisone—systemic lupus erythematosus	0.000146	0.000544	CcSEcCtD
Bosentan—Shock—Dexamethasone—systemic lupus erythematosus	0.000146	0.000542	CcSEcCtD
Bosentan—Shock—Betamethasone—systemic lupus erythematosus	0.000146	0.000542	CcSEcCtD
Bosentan—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000146	0.000541	CcSEcCtD
Bosentan—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000146	0.00054	CcSEcCtD
Bosentan—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000146	0.00054	CcSEcCtD
Bosentan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000145	0.00054	CcSEcCtD
Bosentan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000145	0.00054	CcSEcCtD
Bosentan—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000145	0.000538	CcSEcCtD
Bosentan—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000145	0.000538	CcSEcCtD
Bosentan—Angioedema—Prednisone—systemic lupus erythematosus	0.000145	0.000537	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—F2—systemic lupus erythematosus	0.000145	0.0028	CbGpPWpGaD
Bosentan—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000144	0.000535	CcSEcCtD
Bosentan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000144	0.000535	CcSEcCtD
Bosentan—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000144	0.000534	CcSEcCtD
Bosentan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000144	0.000533	CcSEcCtD
Bosentan—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000144	0.000533	CcSEcCtD
Bosentan—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000144	0.000533	CcSEcCtD
Bosentan—Vertigo—Prednisone—systemic lupus erythematosus	0.000142	0.000528	CcSEcCtD
Bosentan—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000142	0.000528	CcSEcCtD
Bosentan—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000142	0.000527	CcSEcCtD
Bosentan—Syncope—Prednisone—systemic lupus erythematosus	0.000142	0.000527	CcSEcCtD
Bosentan—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000142	0.000526	CcSEcCtD
Bosentan—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000142	0.000525	CcSEcCtD
Bosentan—Anorexia—Betamethasone—systemic lupus erythematosus	0.000142	0.000525	CcSEcCtD
Bosentan—Urticaria—Prednisolone—systemic lupus erythematosus	0.000141	0.000525	CcSEcCtD
Bosentan—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000141	0.000524	CcSEcCtD
Bosentan—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000141	0.000524	CcSEcCtD
Bosentan—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000141	0.000522	CcSEcCtD
Bosentan—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.000522	CcSEcCtD
Bosentan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.00014	0.000521	CcSEcCtD
Bosentan—Pain—Triamcinolone—systemic lupus erythematosus	0.00014	0.000519	CcSEcCtD
Bosentan—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000139	0.000517	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000139	0.00269	CbGpPWpGaD
Bosentan—Hypotension—Betamethasone—systemic lupus erythematosus	0.000139	0.000515	CcSEcCtD
Bosentan—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000139	0.000515	CcSEcCtD
Bosentan—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000138	0.000514	CcSEcCtD
Bosentan—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000138	0.000512	CcSEcCtD
Bosentan—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000138	0.000512	CcSEcCtD
Bosentan—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000137	0.00051	CcSEcCtD
Bosentan—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000137	0.00051	CcSEcCtD
Bosentan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000137	0.00051	CcSEcCtD
Bosentan—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000137	0.000509	CcSEcCtD
Bosentan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000137	0.000508	CcSEcCtD
Bosentan—Chills—Methotrexate—systemic lupus erythematosus	0.000136	0.000507	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000136	0.00263	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000135	0.000502	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000135	0.000502	CcSEcCtD
Bosentan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000135	0.000501	CcSEcCtD
Bosentan—Arthralgia—Prednisone—systemic lupus erythematosus	0.000135	0.000501	CcSEcCtD
Bosentan—Anxiety—Prednisone—systemic lupus erythematosus	0.000134	0.000499	CcSEcCtD
Bosentan—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000134	0.000498	CcSEcCtD
Bosentan—Insomnia—Betamethasone—systemic lupus erythematosus	0.000134	0.000498	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000134	0.0026	CbGpPWpGaD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000134	0.000497	CcSEcCtD
Bosentan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000134	0.000497	CcSEcCtD
Bosentan—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000134	0.000496	CcSEcCtD
Bosentan—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000133	0.000495	CcSEcCtD
Bosentan—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000133	0.000495	CcSEcCtD
Bosentan—Discomfort—Prednisone—systemic lupus erythematosus	0.000133	0.000495	CcSEcCtD
Bosentan—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000133	0.000495	CcSEcCtD
Bosentan—Erythema—Methotrexate—systemic lupus erythematosus	0.000132	0.000491	CcSEcCtD
Bosentan—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000132	0.000491	CcSEcCtD
Bosentan—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000131	0.000487	CcSEcCtD
Bosentan—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000131	0.000485	CcSEcCtD
Bosentan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000131	0.000485	CcSEcCtD
Bosentan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.000484	CcSEcCtD
Bosentan—Urticaria—Triamcinolone—systemic lupus erythematosus	0.00013	0.000483	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.00013	0.00252	CbGpPWpGaD
Bosentan—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.00013	0.000481	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00013	0.00251	CbGpPWpGaD
Bosentan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000129	0.00048	CcSEcCtD
Bosentan—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000129	0.00048	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000129	0.00048	CcSEcCtD
Bosentan—Oedema—Prednisone—systemic lupus erythematosus	0.000129	0.00048	CcSEcCtD
Bosentan—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000129	0.000479	CcSEcCtD
Bosentan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000129	0.000479	CcSEcCtD
Bosentan—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000129	0.000479	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000129	0.0025	CbGpPWpGaD
Bosentan—Infection—Prednisone—systemic lupus erythematosus	0.000128	0.000477	CcSEcCtD
Bosentan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000128	0.000476	CcSEcCtD
Bosentan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000128	0.000476	CcSEcCtD
Bosentan—Back pain—Methotrexate—systemic lupus erythematosus	0.000128	0.000475	CcSEcCtD
Bosentan—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000128	0.000475	CcSEcCtD
Bosentan—Fatigue—Betamethasone—systemic lupus erythematosus	0.000128	0.000475	CcSEcCtD
Bosentan—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000128	0.000475	CcSEcCtD
Bosentan—Shock—Prednisone—systemic lupus erythematosus	0.000127	0.000472	CcSEcCtD
Bosentan—Pain—Betamethasone—systemic lupus erythematosus	0.000127	0.000471	CcSEcCtD
Bosentan—Pain—Dexamethasone—systemic lupus erythematosus	0.000127	0.000471	CcSEcCtD
Bosentan—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000127	0.000471	CcSEcCtD
Bosentan—Tachycardia—Prednisone—systemic lupus erythematosus	0.000126	0.000468	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000126	0.00244	CbGpPWpGaD
Bosentan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000126	0.000468	CcSEcCtD
Bosentan—Skin disorder—Prednisone—systemic lupus erythematosus	0.000126	0.000466	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000125	0.000464	CcSEcCtD
Bosentan—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000125	0.000463	CcSEcCtD
Bosentan—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000125	0.000463	CcSEcCtD
Bosentan—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000124	0.000461	CcSEcCtD
Bosentan—Rash—Cyclosporine—systemic lupus erythematosus	0.000123	0.000458	CcSEcCtD
Bosentan—Anorexia—Prednisone—systemic lupus erythematosus	0.000123	0.000457	CcSEcCtD
Bosentan—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000123	0.000457	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	0.000123	0.00239	CbGpPWpGaD
Bosentan—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000123	0.000456	CcSEcCtD
Bosentan—Headache—Cyclosporine—systemic lupus erythematosus	0.000122	0.000455	CcSEcCtD
Bosentan—Anaemia—Methotrexate—systemic lupus erythematosus	0.000122	0.000454	CcSEcCtD
Bosentan—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000121	0.00235	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000121	0.000451	CcSEcCtD
Bosentan—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000121	0.000451	CcSEcCtD
Bosentan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00045	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000121	0.00235	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000121	0.00234	CbGpPWpGaD
Bosentan—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000121	0.000447	CcSEcCtD
Bosentan—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000446	CcSEcCtD
Bosentan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.000446	CcSEcCtD
Bosentan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.000446	CcSEcCtD
Bosentan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.000444	CcSEcCtD
Bosentan—Vertigo—Methotrexate—systemic lupus erythematosus	0.000119	0.000442	CcSEcCtD
Bosentan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000119	0.000441	CcSEcCtD
Bosentan—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000119	0.00044	CcSEcCtD
Bosentan—Urticaria—Betamethasone—systemic lupus erythematosus	0.000118	0.000438	CcSEcCtD
Bosentan—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000118	0.000438	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—C3—systemic lupus erythematosus	0.000118	0.00228	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000118	0.000437	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000118	0.00228	CbGpPWpGaD
Bosentan—Dizziness—Prednisolone—systemic lupus erythematosus	0.000118	0.000437	CcSEcCtD
Bosentan—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000117	0.000436	CcSEcCtD
Bosentan—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000117	0.000436	CcSEcCtD
Bosentan—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000117	0.000436	CcSEcCtD
Bosentan—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000117	0.000436	CcSEcCtD
Bosentan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000117	0.000436	CcSEcCtD
Bosentan—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000117	0.000435	CcSEcCtD
Bosentan—Insomnia—Prednisone—systemic lupus erythematosus	0.000117	0.000434	CcSEcCtD
Bosentan—Nausea—Cyclosporine—systemic lupus erythematosus	0.000116	0.000431	CcSEcCtD
Bosentan—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000116	0.000431	CcSEcCtD
Bosentan—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000116	0.00043	CcSEcCtD
Bosentan—Cough—Methotrexate—systemic lupus erythematosus	0.000116	0.000429	CcSEcCtD
Bosentan—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000116	0.000429	CcSEcCtD
Bosentan—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000115	0.000427	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000114	0.00222	CbGpPWpGaD
Bosentan—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000114	0.000422	CcSEcCtD
Bosentan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000113	0.000421	CcSEcCtD
Bosentan—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000113	0.000418	CcSEcCtD
Bosentan—Chest pain—Methotrexate—systemic lupus erythematosus	0.000113	0.000418	CcSEcCtD
Bosentan—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000112	0.000417	CcSEcCtD
Bosentan—Rash—Prednisolone—systemic lupus erythematosus	0.000112	0.000416	CcSEcCtD
Bosentan—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000112	0.000416	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000112	0.000416	CcSEcCtD
Bosentan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000112	0.000415	CcSEcCtD
Bosentan—Fatigue—Prednisone—systemic lupus erythematosus	0.000111	0.000414	CcSEcCtD
Bosentan—Headache—Prednisolone—systemic lupus erythematosus	0.000111	0.000414	CcSEcCtD
Bosentan—Discomfort—Methotrexate—systemic lupus erythematosus	0.000111	0.000413	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000111	0.00215	CbGpPWpGaD
Bosentan—Constipation—Prednisone—systemic lupus erythematosus	0.000111	0.00041	CcSEcCtD
Bosentan—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.00011	0.00041	CcSEcCtD
Bosentan—Rash—Hydrocortisone—systemic lupus erythematosus	0.00011	0.000407	CcSEcCtD
Bosentan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000109	0.000406	CcSEcCtD
Bosentan—Headache—Hydrocortisone—systemic lupus erythematosus	0.000109	0.000404	CcSEcCtD
Bosentan—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000108	0.000402	CcSEcCtD
Bosentan—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000108	0.000401	CcSEcCtD
Bosentan—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000108	0.000401	CcSEcCtD
Bosentan—Infection—Methotrexate—systemic lupus erythematosus	0.000107	0.000398	CcSEcCtD
Bosentan—Asthenia—Betamethasone—systemic lupus erythematosus	0.000107	0.000395	CcSEcCtD
Bosentan—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000107	0.000395	CcSEcCtD
Bosentan—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000106	0.000393	CcSEcCtD
Bosentan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000106	0.000393	CcSEcCtD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000106	0.00205	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000106	0.000392	CcSEcCtD
Bosentan—Nausea—Prednisolone—systemic lupus erythematosus	0.000106	0.000392	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000105	0.00204	CbGpPWpGaD
Bosentan—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000105	0.00039	CcSEcCtD
Bosentan—Pruritus—Betamethasone—systemic lupus erythematosus	0.000105	0.00039	CcSEcCtD
Bosentan—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000105	0.00039	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000105	0.00203	CbGpPWpGaD
Bosentan—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000104	0.000388	CcSEcCtD
Bosentan—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000104	0.000386	CcSEcCtD
Bosentan—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000385	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—F2—systemic lupus erythematosus	0.000103	0.002	CbGpPWpGaD
Bosentan—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000103	0.000383	CcSEcCtD
Bosentan—Rash—Triamcinolone—systemic lupus erythematosus	0.000103	0.000383	CcSEcCtD
Bosentan—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000103	0.000383	CcSEcCtD
Bosentan—Anorexia—Methotrexate—systemic lupus erythematosus	0.000103	0.000382	CcSEcCtD
Bosentan—Rash—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000382	CcSEcCtD
Bosentan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000382	CcSEcCtD
Bosentan—Urticaria—Prednisone—systemic lupus erythematosus	0.000103	0.000381	CcSEcCtD
Bosentan—Headache—Triamcinolone—systemic lupus erythematosus	0.000103	0.00038	CcSEcCtD
Bosentan—Headache—Methylprednisolone—systemic lupus erythematosus	0.000102	0.00038	CcSEcCtD
Bosentan—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000102	0.000379	CcSEcCtD
Bosentan—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000102	0.000379	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CSK—systemic lupus erythematosus	0.000102	0.00197	CbGpPWpGaD
Bosentan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000102	0.000377	CcSEcCtD
Bosentan—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000102	0.000377	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	0.000101	0.00197	CbGpPWpGaD
Bosentan—Hypotension—Methotrexate—systemic lupus erythematosus	0.000101	0.000375	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.0001	0.00195	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	9.94e-05	0.00193	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	9.84e-05	0.000365	CcSEcCtD
Bosentan—Dizziness—Betamethasone—systemic lupus erythematosus	9.82e-05	0.000364	CcSEcCtD
Bosentan—Dizziness—Dexamethasone—systemic lupus erythematosus	9.82e-05	0.000364	CcSEcCtD
Bosentan—Insomnia—Methotrexate—systemic lupus erythematosus	9.77e-05	0.000363	CcSEcCtD
Bosentan—Nausea—Triamcinolone—systemic lupus erythematosus	9.72e-05	0.000361	CcSEcCtD
Bosentan—Paraesthesia—Methotrexate—systemic lupus erythematosus	9.7e-05	0.00036	CcSEcCtD
Bosentan—Nausea—Methylprednisolone—systemic lupus erythematosus	9.7e-05	0.00036	CcSEcCtD
Bosentan—Dyspnoea—Methotrexate—systemic lupus erythematosus	9.63e-05	0.000358	CcSEcCtD
Bosentan—Somnolence—Methotrexate—systemic lupus erythematosus	9.61e-05	0.000357	CcSEcCtD
Bosentan—Hypersensitivity—Prednisone—systemic lupus erythematosus	9.53e-05	0.000354	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.52e-05	0.00184	CbGpPWpGaD
Bosentan—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.51e-05	0.000353	CcSEcCtD
Bosentan—Vomiting—Dexamethasone—systemic lupus erythematosus	9.44e-05	0.00035	CcSEcCtD
Bosentan—Vomiting—Betamethasone—systemic lupus erythematosus	9.44e-05	0.00035	CcSEcCtD
Bosentan—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.39e-05	0.000349	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.38e-05	0.00182	CbGpPWpGaD
Bosentan—Rash—Dexamethasone—systemic lupus erythematosus	9.36e-05	0.000347	CcSEcCtD
Bosentan—Rash—Betamethasone—systemic lupus erythematosus	9.36e-05	0.000347	CcSEcCtD
Bosentan—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.35e-05	0.000347	CcSEcCtD
Bosentan—Dermatitis—Betamethasone—systemic lupus erythematosus	9.35e-05	0.000347	CcSEcCtD
Bosentan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	9.33e-05	0.000346	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NCF2—systemic lupus erythematosus	9.32e-05	0.00181	CbGpPWpGaD
Bosentan—Fatigue—Methotrexate—systemic lupus erythematosus	9.32e-05	0.000346	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—C3—systemic lupus erythematosus	9.31e-05	0.0018	CbGpPWpGaD
Bosentan—Headache—Betamethasone—systemic lupus erythematosus	9.3e-05	0.000345	CcSEcCtD
Bosentan—Headache—Dexamethasone—systemic lupus erythematosus	9.3e-05	0.000345	CcSEcCtD
Bosentan—Asthenia—Prednisone—systemic lupus erythematosus	9.28e-05	0.000344	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	9.27e-05	0.0018	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—LYN—systemic lupus erythematosus	9.26e-05	0.00179	CbGpPWpGaD
Bosentan—Pain—Methotrexate—systemic lupus erythematosus	9.24e-05	0.000343	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—CCL2—systemic lupus erythematosus	9.22e-05	0.00179	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	9.21e-05	0.00178	CbGpPWpGaD
Bosentan—Pruritus—Prednisone—systemic lupus erythematosus	9.15e-05	0.00034	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.13e-05	0.00177	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.09e-05	0.00176	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL12—systemic lupus erythematosus	9.03e-05	0.00175	CbGpPWpGaD
Bosentan—Diarrhoea—Prednisone—systemic lupus erythematosus	8.85e-05	0.000328	CcSEcCtD
Bosentan—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	8.84e-05	0.000328	CcSEcCtD
Bosentan—Nausea—Betamethasone—systemic lupus erythematosus	8.82e-05	0.000327	CcSEcCtD
Bosentan—Nausea—Dexamethasone—systemic lupus erythematosus	8.82e-05	0.000327	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.65e-05	0.00167	CbGpPWpGaD
Bosentan—Urticaria—Methotrexate—systemic lupus erythematosus	8.58e-05	0.000319	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.57e-05	0.00166	CbGpPWpGaD
Bosentan—Dizziness—Prednisone—systemic lupus erythematosus	8.55e-05	0.000317	CcSEcCtD
Bosentan—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.54e-05	0.000317	CcSEcCtD
Bosentan—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.54e-05	0.000317	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.52e-05	0.00165	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—C3—systemic lupus erythematosus	8.45e-05	0.00164	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	8.42e-05	0.00163	CbGpPWpGaD
Bosentan—Vomiting—Prednisone—systemic lupus erythematosus	8.22e-05	0.000305	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—TLR9—systemic lupus erythematosus	8.19e-05	0.00159	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—F2—systemic lupus erythematosus	8.17e-05	0.00158	CbGpPWpGaD
Bosentan—Rash—Prednisone—systemic lupus erythematosus	8.15e-05	0.000303	CcSEcCtD
Bosentan—Dermatitis—Prednisone—systemic lupus erythematosus	8.14e-05	0.000302	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	8.12e-05	0.00157	CbGpPWpGaD
Bosentan—Headache—Prednisone—systemic lupus erythematosus	8.1e-05	0.000301	CcSEcCtD
Bosentan—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.01e-05	0.00155	CbGpPWpGaD
Bosentan—Hypersensitivity—Methotrexate—systemic lupus erythematosus	7.96e-05	0.000296	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.94e-05	0.00154	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.93e-05	0.00154	CbGpPWpGaD
Bosentan—Asthenia—Methotrexate—systemic lupus erythematosus	7.75e-05	0.000288	CcSEcCtD
Bosentan—Nausea—Prednisone—systemic lupus erythematosus	7.68e-05	0.000285	CcSEcCtD
Bosentan—Pruritus—Methotrexate—systemic lupus erythematosus	7.64e-05	0.000284	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.49e-05	0.00145	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.45e-05	0.00144	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—F2—systemic lupus erythematosus	7.42e-05	0.00144	CbGpPWpGaD
Bosentan—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.39e-05	0.000274	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—JUNB—systemic lupus erythematosus	7.32e-05	0.00142	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CSK—systemic lupus erythematosus	7.3e-05	0.00141	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	7.26e-05	0.00141	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—JAK1—systemic lupus erythematosus	7.19e-05	0.00139	CbGpPWpGaD
Bosentan—Dizziness—Methotrexate—systemic lupus erythematosus	7.15e-05	0.000265	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.95e-05	0.00135	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	6.9e-05	0.00134	CbGpPWpGaD
Bosentan—Vomiting—Methotrexate—systemic lupus erythematosus	6.87e-05	0.000255	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.82e-05	0.00132	CbGpPWpGaD
Bosentan—Rash—Methotrexate—systemic lupus erythematosus	6.81e-05	0.000253	CcSEcCtD
Bosentan—Dermatitis—Methotrexate—systemic lupus erythematosus	6.81e-05	0.000253	CcSEcCtD
Bosentan—Headache—Methotrexate—systemic lupus erythematosus	6.77e-05	0.000251	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—PRL—systemic lupus erythematosus	6.74e-05	0.00131	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.72e-05	0.0013	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NCF2—systemic lupus erythematosus	6.67e-05	0.00129	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—C3—systemic lupus erythematosus	6.66e-05	0.00129	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LYN—systemic lupus erythematosus	6.63e-05	0.00128	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.61e-05	0.00128	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.53e-05	0.00127	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.5e-05	0.00126	CbGpPWpGaD
Bosentan—Nausea—Methotrexate—systemic lupus erythematosus	6.42e-05	0.000238	CcSEcCtD
Bosentan—ABCB11—Metabolism—NAT2—systemic lupus erythematosus	6.31e-05	0.00122	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.19e-05	0.0012	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.1e-05	0.00118	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—C3—systemic lupus erythematosus	6.05e-05	0.00117	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—TYK2—systemic lupus erythematosus	6e-05	0.00116	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—F2—systemic lupus erythematosus	5.85e-05	0.00113	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.5e-05	0.00107	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—JAK1—systemic lupus erythematosus	5.39e-05	0.00104	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.33e-05	0.00103	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—F2—systemic lupus erythematosus	5.31e-05	0.00103	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JUNB—systemic lupus erythematosus	5.24e-05	0.00101	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCR5—systemic lupus erythematosus	5.11e-05	0.000989	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.03e-05	0.000975	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.01e-05	0.000971	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—systemic lupus erythematosus	5e-05	0.000968	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—C3—systemic lupus erythematosus	4.99e-05	0.000967	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.97e-05	0.000964	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRL—systemic lupus erythematosus	4.82e-05	0.000934	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.73e-05	0.000917	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	4.55e-05	0.000882	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.51e-05	0.000873	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—F2—systemic lupus erythematosus	4.38e-05	0.000849	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.3e-05	0.000832	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CD80—systemic lupus erythematosus	4.2e-05	0.000814	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.94e-05	0.000764	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.94e-05	0.000763	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL2—systemic lupus erythematosus	3.91e-05	0.000757	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JAK1—systemic lupus erythematosus	3.86e-05	0.000747	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—systemic lupus erythematosus	3.66e-05	0.000708	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.6e-05	0.000698	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—systemic lupus erythematosus	3.58e-05	0.000693	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—C3—systemic lupus erythematosus	3.57e-05	0.000692	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TYK2—systemic lupus erythematosus	3.55e-05	0.000687	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—RXRA—systemic lupus erythematosus	3.54e-05	0.000685	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—systemic lupus erythematosus	3.48e-05	0.000674	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.28e-05	0.000635	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—F2—systemic lupus erythematosus	3.14e-05	0.000608	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.02e-05	0.000584	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD80—systemic lupus erythematosus	3.01e-05	0.000582	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—systemic lupus erythematosus	2.95e-05	0.000572	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—systemic lupus erythematosus	2.94e-05	0.000569	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL2—systemic lupus erythematosus	2.8e-05	0.000542	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—systemic lupus erythematosus	2.79e-05	0.000541	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.78e-05	0.000539	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.65e-05	0.000513	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EP300—systemic lupus erythematosus	2.65e-05	0.000513	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TYK2—systemic lupus erythematosus	2.54e-05	0.000492	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.51e-05	0.000486	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—systemic lupus erythematosus	2.49e-05	0.000483	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.3e-05	0.000446	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—systemic lupus erythematosus	2.23e-05	0.000432	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.16e-05	0.000418	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—systemic lupus erythematosus	2.11e-05	0.000409	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	2.11e-05	0.000408	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—systemic lupus erythematosus	2.1e-05	0.000407	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—systemic lupus erythematosus	2.01e-05	0.000389	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—systemic lupus erythematosus	2e-05	0.000387	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.99e-05	0.000386	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—systemic lupus erythematosus	1.92e-05	0.000372	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EP300—systemic lupus erythematosus	1.9e-05	0.000367	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.8e-05	0.000348	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—systemic lupus erythematosus	1.76e-05	0.00034	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—systemic lupus erythematosus	1.73e-05	0.000336	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.67e-05	0.000324	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.65e-05	0.000319	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.51e-05	0.000292	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—EP300—systemic lupus erythematosus	1.46e-05	0.000283	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.39e-05	0.000269	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.32e-05	0.000255	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—systemic lupus erythematosus	1.24e-05	0.000241	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1.18e-05	0.000229	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.1e-05	0.000212	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	7.79e-06	0.000151	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	7.45e-06	0.000144	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	6.7e-06	0.00013	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	6.41e-06	0.000124	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	5.86e-06	0.000114	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	4.92e-06	9.52e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	4.88e-06	9.45e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	4.42e-06	8.56e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	4.23e-06	8.19e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.87e-06	7.49e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	3.22e-06	6.23e-05	CbGpPWpGaD
